SCHEMBL8497734

SCHEMBL8497734

C[C@H](CS[C@@H](CCc1ccccc1C(C)(C)O)c1cccc(C=Cc2ccc3ccc(Cl)cc3n2)c1)C(=O)[O-].[Na+]

nearest known ligand 0.86

Known targets — ChEMBL curated mechanism

ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYSLTR1 known ✓ Q9Y271 2/20 0.76
▸ NR3C1 known ✓ P04150 1/20 0.71
▸ ADORA3 known ✓ P0DMS8 1/20 0.71
▸ PPARG known ✓ P37231 1/20 0.71
▸ PDE4D known ✓ Q08499 1/20 0.71
▸ PDE3A known ✓ Q14432 1/20 0.71
▸ CYP2C8 P10632 2/20 0.76
▸ CYSLTR2 Q9NS75 2/20 0.76
▸ CYP2C9 P11712 1/20 0.76
▸ FPR1 P21462 1/20 0.76
▸ GPR183 P32249 1/20 0.76
▸ MEN1 O00255 1/20 0.71
▸ RECQL P46063 1/20 0.71
▸ BLM P54132 1/20 0.71
▸ KMT2A Q03164 1/20 0.71
▸ ABCB11 O95342 1/20 0.71
▸ EGFR P00533 1/20 0.71
▸ ESR1 P03372 1/20 0.71
▸ FYN P06241 1/20 0.71
▸ PGR P06401 1/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8497471 1.00 CYP2C8 (0.76) CYP2C8CYSLTR2CYSLTR1CYP2C9FPR1
SCHEMBL8498781 1.00 CYP2C8 (0.76) CYP2C8CYSLTR2CYSLTR1CYP2C9FPR1
SCHEMBL8497511 1.00 CYP2C8 (0.76) CYP2C8CYSLTR2CYSLTR1CYP2C9FPR1
SCHEMBL9689095 0.93 MEN1 (0.75) CYP2C8CYSLTR2CYSLTR1MEN1RECQL
SCHEMBL9690891 0.93 MEN1 (0.75) CYP2C8CYSLTR2CYSLTR1MEN1RECQL
SCHEMBL9691021 0.93 MEN1 (0.75) CYP2C8CYSLTR2CYSLTR1MEN1RECQL
SCHEMBL8500061 0.92 CYP2C8 (0.74) CYP2C8CYSLTR2CYSLTR1CYP2C9FPR1
SCHEMBL8499866 0.92 CYP2C8 (0.74) CYP2C8CYSLTR2CYSLTR1CYP2C9FPR1
SCHEMBL8500751 0.91 CYP2C8 (0.70) CYP2C8CYSLTR2CYSLTR1CYP2C9FPR1
SCHEMBL9690557 0.89 CYP2C8 (0.74) CYP2C8CYSLTR2CYSLTR1CYP2C9FPR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5856322-A ANTIALLERGENS, ANTIINFLAMMATORY AGENTS, CARDIOVASCULAR DISORDERS MERCK FROSST CANADA, INC. (CA) 1999-01-05 — — US disclosed
EP-0480717-B1 Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists MERCK FROSST CANADA INC (CA) 1998-04-15 — — EP disclosed
US-5565473-A USEFUL AS ANTI-ASTHMATIC, ANTI-ALLERGIC, ANTI-INFLAMMATORY AND CYTOPROTECTIVE AGENTS; MONTELUKAST AND ITS SODIUM SALT MERCK FROSST CANADA, INC. (CA) 1996-10-15 — — US disclosed
US-5270324-A Fluorinated hydroxyalkylquinoline acids as leukotriene antagonists MERCK FROSST CANADA, INC. (CA) 1993-12-14 — — US disclosed
Send feedback